SmallCap
CompaniesMapStatistics

오름테라퓨틱 주식회사

Listed
Venture Certified
Data Quality: 95/10

Basic Information


Listed

Stock Code: 475830

Company Name오름테라퓨틱 주식회사
English NameOrum Therapeutics, Inc.
Business Reg. No.8878100503
CEO이승주
Address대전광역시 유성구 문지로 281-25
Industry의학 및 약학 연구개발업
Industry Code211
Main Products용역매출
Established2016-08-17
Phone042-716-3030
WebsiteContact
Regular Employees23persons
Corp. Reg. No.1601110433518

Investment Metrics


Market Cap
-
Op. Margin
-45.71%
ROE
-5.74%
Debt Ratio
38.11%

Certification Status


Venture Certified

Cert. History
벤처투자유형2016-09-13 ~ 2018-09-12201603004402016-09-13
벤처투자유형2018-09-13 ~ 2020-09-12201803006692016-09-13
벤처투자유형2020-09-13 ~ 2022-09-12202003011072016-09-13
벤처투자유형2022-09-13 ~ 2025-09-12202209280100142016-09-13
벤처투자유형2025-12-09 ~ 2028-12-08202512090100512016-09-13

Financial Statements


3-Year Financial Data

Revenue CAGR +1559.4%

Item202420232022
Revenue

209B

1,354B

0.8B

Operating Profit

-96B

979B

-469B

Net Profit

-66B

702B

-663B

Total Assets

1,576B

1,645B

225B

Total Liabilities

435B

402B

180B

Total Equity

1,141B

1,243B

45B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
209B

69.1%

vs. 3-Year Avg.: 677B
Operating Profit
-96B

137.4%

vs. 3-Year Avg.: 255B
Op. Margin
-45.7%

99.9%

vs. 3-Year Avg.: -30822.1%
Debt Ratio
38.1%

82.4%

vs. 3-Year Avg.: 216.6%
ROE
-5.7%

99.2%

vs. 3-Year Avg.: -708.6%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
이승주대표이사대표

Employment Status


NPS Subscribers

23persons

CEO이승주
Est. Avg. Annual Salary

6,22110K

(51810K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+1persons

Left (12 mo)

-0persons

Net Change (12 mo)

+1persons

NPS Join Date

2016-08-17

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

17 Patents
1 Registered
2 in 3 Years
A61 의학/수의학/위생 (33)
C07 유기화학 (32)
C12 생화학/미생물학 (2)
Patent TitleApplicantApplication No.Filing DateStatus
신규분해약물 접합체오름테라퓨틱 주식회사10202570109242023-10-06공개
효과기 T세포의 활성화제오름테라퓨틱 주식회사10202470334232023-03-08공개
항체 약물 접합체에 사용하기 위한 링커오름테라퓨틱 주식회사10202470115752022-09-07공개
신규분해제-항-CD33 항체 접합체오름테라퓨틱 주식회사|브리스톨-마이어스 스큅 컴퍼니10202470001002022-06-02공개
신규분해제 접합체오름테라퓨틱 주식회사|브리스톨-마이어스 스큅 컴퍼니10202470000992022-06-02공개

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "대전광역시 유성구 문지로",
  "brno": "887810****",
  "cappedWarning": false,
  "companyName": "오름테라퓨틱주식회사",
  "estimatedAvgAnnualSalary": 62214588,
  "estimatedAvgMonthlySalary": 5184549,
  "fetchedAt": "2026-03-05T11:41:17.846Z",
  "industryCode": "730000",
  "industryName": "기타 인문 및 사회과학 연구개발업",
  "joinDate": "20160817",
  "last12MonthsHired": 1,
  "last12MonthsLeft": 0,
  "last12MonthsNetChange": 1,
  "leaveDate": null,
  "monthlyPensionAmount": 11328240,
  "monthlyTrend": [
    {
      "lostSubscribers": 0,
      "newSubscribers": 1,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6769766",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 23,
  "turnoverMonths": 1
}

{
  "address": "대전 유성구",
  "ceo_name": "이승주",
  "certificate": [
    {
      "cert_number": "20160300440",
      "changes": "",
      "disclosure_date": "2016-09-13",
      "first_cert_date": "2016-09-13",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2016-09-13 ~ 2018-09-12"
    },
    {
      "cert_number": "20180300669",
      "changes": "",
      "disclosure_date": "2018-10-11",
      "first_cert_date": "2016-09-13",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2018-09-13 ~ 2020-09-12"
    },
    {
      "cert_number": "20200301107",
      "changes": "",
      "disclosure_date": "2020-09-24",
      "first_cert_date": "2016-09-13",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2020-09-13 ~ 2022-09-12"
    },
    {
      "cert_number": "20220928010014",
      "changes": "",
      "disclosure_date": "2022-09-28",
      "first_cert_date": "2016-09-13",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2022-09-13 ~ 2025-09-12"
    },
    {
      "cert_number": "20251209010051",
      "changes": "",
      "disclosure_date": "2025-12-09",
      "first_cert_date": "2016-09-13",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2025-12-09 ~ 2028-12-08"
    }
  ],
  "company_name": "오름테라퓨틱 주식회사",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 138267184000,
      "cost_of_sales": 0,
      "current_assets": 11332548000,
      "current_liabilities": 16703134000,
      "gross_profit": 75923000,
      "net_income": -66272732000,
      "net_income_bs": -66272732000,
      "non_current_assets": 11188680000,
      "non_current_liabilities": 1320886000,
      "non_operating_expenses": 20940222000,
      "non_operating_income": 1524467000,
      "operating_profit": -46856977000,
      "revenue": 75923000,
      "sga_expenses": 46932900000,
      "total_assets": 22521228000,
      "total_equity": 4497208000,
      "total_liabilities": 18024020000
    },
    "2023": {
      "capital_stock": 185839480000,
      "cost_of_sales": 0,
      "current_assets": 124752037000,
      "current_liabilities": 16730557000,
      "gross_profit": 135417607000,
      "net_income": 70165350000,
      "net_income_bs": 70057401000,
      "non_current_assets": 39726624000,
      "non_current_liabilities": 23445932000,
      "non_operating_expenses": 29717553000,
      "non_operating_income": 1955164000,
      "operating_profit": 97927739000,
      "revenue": 135417607000,
      "sga_expenses": 37489868000,
      "total_assets": 164478661000,
      "total_equity": 124302172000,
      "total_liabilities": 40176489000
    },
    "2024": {
      "capital_stock": 1842912000,
      "cost_of_sales": 0,
      "current_assets": 120113889000,
      "current_liabilities": 43288901000,
      "gross_profit": 20905621000,
      "net_income": -6551466000,
      "net_income_bs": -6563841000,
      "non_current_assets": 37517365000,
      "non_current_liabilities": 207754000,
      "non_operating_expenses": 8206113000,
      "non_operating_income": 11210463000,
      "operating_profit": -9555816000,
      "revenue": 20905621000,
      "sga_expenses": 30461437000,
      "total_assets": 157631254000,
      "total_equity": 114134599000,
      "total_liabilities": 43496655000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "1,714,520,000",
      "changes": "1,714,520,000",
      "date": "2023-05-26"
    },
    {
      "amount": "10,000,000,000",
      "changes": "10,000,000,000",
      "date": "2021-04-09"
    },
    {
      "amount": "11,007,996,000",
      "changes": "11,007,996,000",
      "date": "2019-07-09"
    }
  ],
  "main_products": "용역매출",
  "phone": "042-716-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected